About Us
Discover our
story and vision
Our team is built from top researchers, physicians and oncology data specialists.
Our vision
We believe in transparently sharing our results and methods. You can view our published and submitted manuscripts on our insights page.
We’d point to our leadership in creating a consortium of over 20 NCI-designated cancer centers, along with Ci4CC. The group, named the Collaboration for Oncology focused LLM Training (COLT), recognizes that generative AI is a nascent technology and oncology is a zero-fail space. We therefore partner together to share best practices, and determine performance benchmarks and safety standards.
Swipe right to scroll.
%201.jpg)
Sarim Khan
Co-Founder and CEO
%201.jpg)
Hrituraj Singh
Co-Founder and CTO
Regina Schwind
Clinical Data
Sebastien Rhodes
Strategy and Operations
Daniel Novinson
Medical Director
Aniket Jaiswal
GTM & Market Intelligence
Paul Deleanu
Security and Compliance
Surbhi Chamoli
Design
Mauro Nievas
AI/ML
Yashwardhan Singh
Product Management
Press mentions
We're honored to have received coverage in several media outlets.
Our Investors
Our investors include Lightspeed, Nexus, Y Combinator, and General Catalyst, firms with a track record of expertise in AI and digital health.
Our investors
Our investors include Lightspeed, Nexus, Y Combinator, and General Catalyst, firms with a track record of expertise in AI and digital health.
Core Values
Finally, we recognize that generative AI is a new technology and any model, no matter how well developed, will have limitations. Accordingly, we strive for:
01
True Collaboration
Success in healthcare AI often requires collaborative efforts. We foster teamwork not only within our company but also with our partner providers, integrating their insights to continually refine and enhance our AI and software. Together, we create solutions that are more than the sum of their parts.
02
Constant Support
We provide continuous support and tailored learning opportunities for our end users to ensure they can best utilize our solutions. Our goal is to empower healthcare professionals with advanced tools needed for optimal patient care and innovative research.
03
Responsible Innovation
In the critical field of oncology, we hold ourselves to the highest standards of ethical innovation. Our work is provider- and patient-centric, ensuring that our advancements in healthcare AI are developed responsibly, with a commitment to doing no harm and prioritizing safety above all.
04
Meaningful Impact
Our focus is on creating a significant positive impact in the lives of cancer patients and the healthcare teams who care for them. We measure success by the real-world utility and effectiveness of our solutions, aiming to transform oncology care through technology.
OUR RESULTS
We believe in transparently sharing our results and methods. You can view our published and submitted manuscripts on our insights page.
OUR PARTNERS
We’d point to our leadership in creating a consortium of over 20 NCI-designated cancer centers, along with Ci4CC. The group, named the Collaboration for Oncology focused LLM Training (COLT), recognizes that generative AI is a nascent technology and oncology is a zero-fail space. We therefore partner together to share best practices, and determine performance benchmarks and safety standards.
PRESS MENTIONS
Article Link
Article Link
Article Link
Article Link
PRESS MENTIONS
We're honored to have been featured in over 40 outlets, including:
Article Link
Article Link
Article Link
Article Link
PRESS MENTIONS
We're honored to have received coverage in several media outlets.
(Click on each logo below to read the corresponding article.)
OUR INVESTORS
Our investors include Lightspeed, Nexus, Y Combinator, and General Catalyst, firms with a track record of expertise in AI and digital health.
Finally, we recognize that generative AI is a new technology and any model, no matter how well developed, will have limitations. Accordingly, we strive for:
01
True Collaboration
Success in healthcare AI often requires collaborative efforts. We foster teamwork not only within our company but also with our partner providers, integrating their insights to continually refine and enhance our AI and software. Together, we create solutions that are more than the sum of their parts.
02
Constant Support
We provide continuous support and tailored learning opportunities for our end users to ensure they can best utilize our solutions. Our goal is to empower healthcare professionals with advanced tools needed for optimal patient care and innovative research.
03
Responsible Innovation
In the critical field of oncology, we hold ourselves to the highest standards of ethical innovation. Our work is provider- and patient-centric, ensuring that our advancements in healthcare AI are developed responsibly, with a commitment to doing no harm and prioritizing safety above all.
04
Meaningful Impact
Our focus is on creating a significant positive impact in the lives of cancer patients and the healthcare teams who care for them. We measure success by the real-world utility and effectiveness of our solutions, aiming to transform oncology care through technology.
Swipe right to scroll.
Swipe right to scroll.
CONTACT US
888-ONCO-LLM
(888-662-6556)
1 World Trade Center, Ste. 46C
New York, NY 10007